ESPR stock – Knox Daily

Analysts Viewpoint

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Stock Earnings

Esperion Therapeutics Inc’s recent filing unveils that its Officer Warren Eric acquired Company’s shares for reported $5426.0 on Dec 17

Insiders Updates

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Stock Earnings

Esperion Therapeutics Inc’s filing revealed that its Chief Commercial Officer Warren Eric unloaded Company’s shares for reported $427.0 on Nov

Analysts Viewpoint

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Analysts Viewpoint

Esperion Therapeutics Inc’s recently made public that its Chief Commercial Officer Warren Eric unloaded Company’s shares for reported $427.0 on

Insiders Updates

In a filing, Esperion Therapeutics Inc revealed its Chief Commercial Officer Warren Eric unloaded Company’s shares for reported $427.0 on

Insiders Updates

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Insiders Updates

In a filing, Esperion Therapeutics Inc revealed its Chief Commercial Officer Warren Eric unloaded Company’s shares for reported $227.0 on

Analysts Viewpoint

In a filing, Esperion Therapeutics Inc revealed its Chief Commercial Officer Warren Eric unloaded Company’s shares for reported $227.0 on

Tag: ESPR stock